FibroBiologics, Inc. SEC filings FBLG
FibroBiologics, Inc. has 242 filings in SEC EDGAR's recent list, going back to Jan 31, 2023. Its latest annual report, Form ARS, was filed on May 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 31, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, new debt, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Sep 9, 2026 | — |
| DEF 14A | Proxy statement | Jul 31, 2026 | Sep 17, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 17, 2026 | Sep 17, 2026 |
| DEFA14A | Additional proxy material | May 5, 2026 | — |
| DEF 14A | Proxy statement | May 5, 2026 | May 5, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 22, 2026 | Apr 22, 2026 |
| DEFA14A | Additional proxy material | Dec 29, 2025 | — |
| DEF 14A | Proxy statement | Dec 29, 2025 | Feb 20, 2026 |
| PRE 14A | Preliminary proxy statement | Dec 18, 2025 | Dec 18, 2025 |
| DEF 14A | Proxy statement | Dec 18, 2025 | Dec 18, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Dec 31, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Jul 8, 2024 | — |
| DEF 14A | Proxy statement | Jul 8, 2024 | Jul 8, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 27, 2024 | Jun 27, 2024 |
Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FBLG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1958777
- Former names
- FibroBiologics Inc. (until Feb 6, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.